Gyndora

Gyndora is a combined oral contraceptive tablet containing the synthetic progestogen drospirenone and the estrogen ethinylestradiol. It is marketed in the European Union and is supplied as an oral tablet; the specific strength is not disclosed in the source data. Gyndora belongs to the hormonal contraceptive class and works by preventing ovulation, altering cervical mucus, and modifying the endometrial lining to reduce the chance of pregnancy.

Gyndora is indicated for the prevention of unintended pregnancy in women of reproductive age who choose an oral hormonal method.

- Primary use as a combined oral contraceptive for pregnancy prevention. - Provides cycle regulation for women with irregular menstrual cycles. - May be prescribed to reduce the risk of ovarian cyst formation. - Can be part of a comprehensive family planning strategy when used consistently. - Selected for its lower androgenic activity compared with some other progestins. - Used as a reliable, reversible contraceptive method.

Like other combined oral contraceptives, Gyndora may cause a range of side effects, most of which are mild and transient, while rare serious reactions can occur.

Common: - Nausea or mild stomach upset. - Headache or migraine onset. - Breast tenderness or enlargement. - Spotting or breakthrough bleeding between periods.

Serious: - Deep vein thrombosis or pulmonary embolism. - Severe allergic reaction such as rash, swelling, or difficulty breathing.

Before starting Gyndora, clinicians should evaluate individual risk factors and contraindications to ensure safe use.

- Not recommended for women who are pregnant, breastfeeding, or planning pregnancy. - Contraindicated in individuals with a history of thromboembolic disorders, stroke, or myocardial infarction. - Caution advised for smokers over 35 years of age due to increased cardiovascular risk. - Liver disease or impaired liver function may affect hormone metabolism and should be assessed. - Use with caution in patients with hypertension, diabetes, or migraine with aura. - Avoid use in combination with certain enzyme‑inducing drugs that may reduce efficacy.

Gyndora can interact with other medicines, which may alter its contraceptive effectiveness or increase the risk of adverse events.

Avoid: - Antiepileptic enzyme inducers such as carbamazepine, phenytoin, phenobarbital, and primidone. - Rifampin and other potent rifamycin antibiotics. - Certain antiretroviral agents (e.g., efavirenz, nevirapine). - St. John’s wort herbal supplement.

Use with caution: - Antifungal agents like ketoconazole and itraconazole. - Certain antibiotics (e.g., clarithromycin, erythromycin). - Selective serotonin reuptake inhibitors (SSRIs) that may increase bleeding risk.